1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Ying, J. Ahn, J.-M. Jacobsen, N.E. Brown, M.F. Hruby, V.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 42 2825 2835 10.1021/bi026629r 12627948 NMR Solution Structure of the Glucagon Antagonist [desHis1, desPhe6, Glu9]Glucagon Amide in the Presence of Perdeuterated Dodecylphosphocholine Micelles 2003 10.2210/pdb1nau/pdb pdb_00001nau 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 3213.495 Glucagon DEL(H53), DEL(F58), D7E 1 syn polymer Glicentin-related polypeptide (GRPP) no yes SQGTTSEYSKYLDSRRAQDFVQWLMNT(NH2) SQGTTSEYSKYLDSRRAQDFVQWLMNTX A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_ref_seq_dif struct_site repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2003-03-18 1 1 2008-04-28 1 2 2011-07-13 1 3 2021-10-27 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_conn.pdbx_leaving_atom_flag _struct_ref_seq_dif.details _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id RCSB Y RCSB 2002-11-28 REL REL This sequence was chemically synthesized. It was obtained by modifying the sequence of glucagon, which occurs naturally in Homo sapiens (human). sample This structure was determined using standard 2D homonuclear techniques. 15 structures with the lowest restraint energy 50 16 DQF-COSY 2D TOCSY 2D NOESY 50 mM sodium phosphate; 1mM sodium azide 6.0 ambient 310 K The structures are based on a total of 486 restraints, 475 are NOE-derived distance restraints, 11 dihedral angle restraints distance geometry, restrained molecular dynamics 1 minimized average structure 7mM [desHis1, desPhe6, Glu9]Glucagon Amide; 50 mM sodium phosphate buffer; 283 mM dodecylphosphocholine-d38 micelles; 1 mM sodium azide; 90% H2O, 10% D2O 90% H2O/10% D2O Bruker collection UXNMR Accelrys processing Felix 2000 Accelrys data analysis Felix 2000 Accelrys structure solution DGII within InsightII 2000 Accelrys refinement Discover within InsightII 2000 500 Bruker AMX SER 1 n 1 SER 1 A GLN 2 n 2 GLN 2 A GLY 3 n 3 GLY 3 A THR 4 n 4 THR 4 A THR 5 n 5 THR 5 A SER 6 n 6 SER 6 A GLU 7 n 7 GLU 7 A TYR 8 n 8 TYR 8 A SER 9 n 9 SER 9 A LYS 10 n 10 LYS 10 A TYR 11 n 11 TYR 11 A LEU 12 n 12 LEU 12 A ASP 13 n 13 ASP 13 A SER 14 n 14 SER 14 A ARG 15 n 15 ARG 15 A ARG 16 n 16 ARG 16 A ALA 17 n 17 ALA 17 A GLN 18 n 18 GLN 18 A ASP 19 n 19 ASP 19 A PHE 20 n 20 PHE 20 A VAL 21 n 21 VAL 21 A GLN 22 n 22 GLN 22 A TRP 23 n 23 TRP 23 A LEU 24 n 24 LEU 24 A MET 25 n 25 MET 25 A ASN 26 n 26 ASN 26 A THR 27 n 27 THR 27 A NH2 28 n 28 NH2 28 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 A TYR 11 0.087 SIDE CHAIN 2 A TYR 8 0.077 SIDE CHAIN 12 A TYR 11 0.062 SIDE CHAIN 16 A TYR 11 0.072 SIDE CHAIN 1 A THR 5 41.92 -109.24 1 A ASP 13 -82.79 -115.87 1 A SER 14 -96.68 -114.11 2 A GLN 2 -164.39 -46.58 2 A THR 4 -149.91 -149.29 2 A GLU 7 -90.37 58.48 2 A TYR 8 -160.07 -69.18 2 A ARG 15 -171.73 -49.83 3 A ARG 15 -179.47 -55.73 4 A TYR 11 -86.69 47.51 4 A LEU 12 -134.61 -47.00 4 A ASP 13 -37.88 -95.53 4 A SER 14 -140.73 -114.93 5 A TYR 11 -85.07 42.08 5 A ASP 13 -73.66 -138.87 5 A SER 14 -94.30 -101.58 6 A THR 4 -142.38 17.50 6 A THR 5 -147.14 -61.37 6 A TYR 8 -164.99 -60.11 6 A LEU 12 -151.22 67.28 6 A ASP 13 -140.34 -130.23 7 A THR 4 -162.33 36.77 7 A THR 5 -143.52 -70.23 7 A ASP 13 -74.93 -123.06 7 A SER 14 -120.51 -86.54 8 A THR 4 -100.63 -95.48 8 A GLU 7 -89.58 -73.27 8 A ASP 13 -78.45 -118.83 8 A SER 14 -100.73 -108.09 9 A ASP 13 -70.98 -137.80 9 A SER 14 -89.99 -106.72 10 A THR 4 -156.28 -58.95 10 A LEU 12 -138.44 -44.80 10 A ASP 13 -40.34 -92.43 10 A SER 14 -150.09 -103.96 11 A THR 5 49.68 -96.31 11 A TYR 11 -91.03 53.44 11 A ASP 13 -78.22 -124.20 11 A SER 14 -94.28 -110.82 12 A THR 5 45.76 -97.21 12 A LEU 12 -141.64 -43.98 12 A ASP 13 -39.57 -95.65 12 A SER 14 -150.40 -93.87 13 A THR 4 -157.67 -62.10 13 A ASP 13 -77.03 -126.09 13 A SER 14 -104.62 -114.45 14 A GLN 2 43.92 -117.32 14 A GLU 7 -90.12 -61.48 14 A SER 14 -130.29 -99.87 14 A ARG 15 -156.70 29.32 15 A THR 4 -107.41 -109.64 15 A THR 5 -143.91 -61.34 15 A ARG 15 -179.07 -54.48 16 A TYR 11 -86.75 49.81 16 A LEU 12 -141.13 -40.24 16 A ASP 13 -40.95 -91.44 16 A SER 14 -143.73 -115.27 minimized average NMR Solution Structure of the Glucagon Antagonist [desHis1, desPhe6, Glu9]Glucagon Amide in the Presence of Perdeuterated Dodecylphosphocholine Micelles 1 N N A THR 5 A THR 5 HELX_P A TYR 11 A TYR 11 1 1 7 A SER 14 A SER 14 HELX_P A THR 27 A THR 27 1 2 14 covale 1.335 both A THR 27 A C THR 27 1_555 A NH2 28 A N NH2 28 1_555 HORMONE/GROWTH FACTOR HELIX, TURN, HORMONE-GROWTH FACTOR COMPLEX GLUC_HUMAN UNP 1 53 P01275 HSQGTFTSDYSKYLDSRRAQDFVQWLMNT 53 81 1NAU 1 27 P01275 A 1 1 27 1 HIS deletion 1NAU A P01275 UNP 53 1 PHE deletion 1NAU A P01275 UNP 58 1 ASP engineered mutation GLU 7 1NAU A P01275 UNP 61 7 BINDING SITE FOR RESIDUE NH2 A 28 A NH2 28 Software 2 A ASN 26 A ASN 26 2 1_555 A THR 27 A THR 27 2 1_555